Synthesis of ent-BE-43547A1 reveals a potent hypoxia-selective anticancer agent and uncovers the biosynthetic origin of the APD-CLD natural products

Nikolaj L. Villadsen, Kristian M. Jacobsen, Ulrik B. Keiding, Esben T. Weibel, Bjørn Christiansen, Thomas Vosegaard, Morten Bjerring, Frank Jensen, Mogens Johannsen, Thomas Tørring, Thomas B. Poulsen
  • Nature Chemistry, November 2016, Nature Publishing Group
  • DOI: 10.1038/nchem.2657

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

The following have contributed to this page: Dr Mogens Johannsen and Prof. Frank Jensen